Background Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) are often effective in lung adenocarcinoma individuals with anaplastic lymphoma kinase (ALK) rearrangement. neuroendocrine adjustments were noticeable on second biopsy. After that she was treated with ceritinib and accomplished a incomplete response. Summary We claim that ALK-rearranged adenocarcinoma with mixed neuroendocrine component is usually attentive to ALK-TKIs.… Continue reading Background Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) are often effective